Chryssa Kanellopoulou

Chryssa Kanellopoulou is an accomplished professional in the field of immunology with extensive experience in drug development and research. Currently serving as Executive Director and Head of Immunology at Incyte since October 2022, Kanellopoulou has held various roles within the company, including Sr. Director and Director. Prior to this, a position as Director of Early Drug Development was held at NextCure, Inc., and an Associate Director of Preclinical and Translational Research role at KinaRx. Additional experience includes time at the National Institutes of Health, Dana-Farber Cancer Institute, and training as a PhD student at the Institute for Genetics and EMBL. Kanellopoulou holds a PhD in genetics from the University of Cologne and a Bachelor's degree in Biology from Ethnikon kai Kapodistriakon Panepistimion Athinon.